Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Drug use and homelessness were among the top reported risk factors during the 2016 to 2022 hepatitis A outbreak.
Telemedicine treatment was twice as successful in curing hepatitis C compared with typical offsite referral.
Among those aged 35 to 44, overdose mortality more than tripled during this period, NIH study reports.
Treatment options like buprenorphine are rendered less effective by the prevalence of fentanyl, xylazine and other synthetic drugs.
At a suggested retail price of $44.99 per pack, affordability can be a barrier to access.
NIH study suggests brain’s salience network is important for understanding substance use disorders.
Initiating HCV treatment during a hospital stay helped more people complete antiviral treatment and achieve a cure.
Offering hepatitis C treatment at the point of diagnosis streamlines care, saving both time and money.
Study findings suggest this circuitry might be targeted in potential therapies for a variety of substance use disorders.
Hepatitis C prevalence was higher among people with unstable housing and those who injected drugs every day.
Modern antivirals can cure 95% of people with HCV, lowering the risk of cirrhosis, liver cancer and liver failure.
The awards to states and local health departments marked Overdose Awareness Day on August 31.
NIH and CDC study finds telehealth associated with increased likelihood of receiving evidence-based standard of care.
The CDC estimates that 21% of people living with HIV also have hepatitis C virus.
Hepatitis A and B declined in 2021, but new hepatitis C cases have doubled since 2014.
Drug-related mortality, including overdose, was the leading cause of death.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.